Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 6 18-6, 1998, Pages

  Thompson, David C ^a,c   Porter, Stephanie E ^a   Bauer, Alison K ^a   Das, Kumuda C ^b   Ou, Brandon ^a   Dwyer Nield, Lori ^a   White, Carl W ^b   Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Neoplasia

Indexed keywords

CYTOKINE; CYTOMIX; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; IMMUNOBLOTTING; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG TUMOR; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031799386     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.6.l922     Document Type: Article

References (67)

1. Adcock, I. M. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch. Chest Dis. 52: 178-186, 1997.
2. Arias-Díaz, J., E. Vara, J. Torres-Melero, C. García, W. Baki, J. A. Ramírez-Armengol, and J. E. Balibrea. Nitrite/ nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer 74: 1546-1551, 1994.
3. Asano, K., C. B. E. Chee, B. Gaston, C. M. Lilly, C. Gerard, J. M. Drazen, and J. S. Stammler. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA 91: 10089-10093, 1994.
4. Bani, D., E. Masini, M. G. Bello, M. Bigazzi, and T. B. Sacchi. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res. 55: 5272-5275, 1995.
5. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Chem. 72: 248-251, 1976.
6. Broug-Holub, E., and G. Kraal. Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids. Clin. Exp. Immunol. 104: 332-336, 1996.
7. Brown, T, and K. Mackey. Analysis of RNA by Northern and slot blot hybridization. In: Current Protocols in Molecular Biology, edited by F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strahl. Philadelphia, PA: Wiley, 1997, p. 4.9.1-4.9.16.
8. Bucala, R., and H. Vlassara. Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis. 26: 875-888, 1995.
9. Carmichael, J., J. B. Mitchell, W. G. DeGraff, J. Gamson, A. F. Gazdar, B. E. Johnson, E. Glatstein, and J. D. Minna. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br. J. Cancer 57: 540-547, 1988.
10. Chhatwal, V. J. S., S. M. Moochhala, S. T. F. Chan, and S. S. Ngoi. Nitric oxide and cancer. Med. Hypotheses 46: 21-24, 1996.
11. Cobbs, C. S., J. E. Brenman, K. D. Aldape, D. S. Bredt, and M. A. Israel. Expression of nitric oxide in human central nervous system tumors. Cancer Res. 55: 727-730, 1995.
12. Das, K. C., Y. Lewis-Molock, and C. W. White. Thiol modulation of TNF-α and IL-1 induced MnSOD gene expression and activation of NF-κB. Mol. Cell. Biochem. 148: 45-57, 1995.
13. Dimmeler, S., and A. M. Zeiher. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275-281, 1997.
14. Di Rosa, M., M. Radomski, R. Carnuccio, and S. Moncada. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172: 1246-1252, 1990.
15. Dong, Z., A. H. Staroselsky, X. Qi, K. Xie, and I. J. Fidler. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54: 789-793, 1994.
16. Douglas, W. H., and M. E. Kaighn. Clonal isolation of differentiated rat lung cells. In Vitro (Rockville) 10: 230-237, 1974.
17. Edwards, P., J. C. Cendan, D. B. Topping, L. L. Moldawer, S. MacKay, E. M. Copeland III, and D. S. Lind. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res. 63: 49-52, 1996.
18. Felley-Bosco, E., S. Arabs, C. J. Lowenstein, L. K. Keefer, and C. C. Harris. Constitutive expression of inducible nitric oxide synthase in human bronchial epithelial cells induces c-fos and stimulates the cGMP pathway. Am. J. Respir. Cell Mol. Biol. 11: 159-164, 1994.
19. Flodström, M., and D. L. Eizirik. Interferon-γ-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138: 2747-2753, 1997.
20. Garner, M. M., and A. Revzin. A gel electrophoresis method for qualifying the binding of proteins to specific DNA regions: application to components of Escherichia coli lactase Operon regulatory system. Nucleic Acids Res. 9: 3047-3059, 1981.
21. Giard, D. J., S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey, H. Dosik, and W. P. Parks. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51: 1417-1423, 1973.
22. Goodwin, C. J., S. J. Holt, S. Downes, and N. J. Marshall. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Methods 179: 95-105, 1995.
23. Gronemeyer, H. Control of transcription activation by steroid hormone receptors. FASEB J. 6: 2524-2529, 1992.
24. Guiterrez, H. H., B. R. Pitt, M. Schwarz, S. C. Watkins, C. Lowenstein, I. Canniggia, P. Chumley, and B. A. Freeman. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L501-L508, 1995.
25. Hamid, Q., D. B. Springall, V. Riveros-Moreno, P. Chanez, P. Howarth, A. Redington, J. Bousquet, P. Godard, S. Holgate, and J. Polak. Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513, 1993.
26. Hoffman, G., J. Grote, F. Friedrich, N. Mutz, and W. Schobersberger. The pulmonary epithelial cell line L 2 as a new model for an inducible nitric oxide synthase expressing distal airway epithelial cell. Biochem. Biophys. Res. Commun. 217: 575-583, 1995.
27. Hybertson, B. M., A. J. Dunham, D. C. Thompson, L. S. Terada, and J. E. Repine. Flow injection analysis of nitrite generated by neutrophils and endothelial cells. Anal. Lett. 27: 3081-3093, 1994.
28. Jany, B., R. Betz, and R. Schreck. Activation of the transcription factor NF-κB in human tracheobronchial epithelial cells by inflammatory stimuli. Eur. J. Respir. Dis. 8: 387-391, 1995.
29. Jenkins, D. C., I. G. Charles, L. L. Thomsen, D. W. Moss, L. S. Holmes, S. A. Baylis, P. Rhodes, K. Westmore, P. C. Emson, and S. Moncada. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92: 4392-4396, 1995.
30. Kharitonov, S. A., A. U. Wells, B. J. O'Connor, D. M. Hansell, P. J. Cole, and P. J. Barnes. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Crit. Care 151: 1889-1893, 1996.
31. Kharitonov, S. A., D. Yates, and P. J. Barnes. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 8: 295-297, 1995.
32. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. Shinebourne, and P. J. Barnes. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994.
33. Kunz, D., G. Walker, W. Eberhardt, and J. Pfeilschifter. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA 93: 255-259, 1996.
34. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174: 761-767, 1991.
35. Lenardo, M. J., and D. Baltimore. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229, 1988.
36. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179: 442-448, 1994.
37. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90: 9730-9734, 1993.
38. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
39. Malkinson, A. M., L. D. Dwyer-Nield, P. L. Rice, and D. Dinsdale. Mouse lung epithelial cell lines-tools for the study of differentiation and the neoplastic phenotype. Toxicology 123: 53-100, 1997.
40. Marsden, P. A., and B. J. Ballermann. Tumor necrosis factor α activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J. Exp. Med. 172: 1843-1852, 1990.
41. Martin, E., C. Nathan, and Q.-W. Xie. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180: 977-984, 1994.
42. Marton, L. J., and D. R. Morris. Molecular and cellular functions of the polyamines. In: Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, edited by P. P. McCann, A. E. Pegg, and A. Sjoersdma. New York: Academic, 1987, p. 79-105.
43. Misko, T. P., W. M. Moore, T. P. Kasten, G. A. Nickols, J. A. Corbett, R. G. Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233: 119-125, 1993.
44. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
45. Moochhala, S., V. J. S. Chhatwal, S. T. F. Chan, S. S. Ngoi, Y. W. Chia, and A. Rauff. Nitric oxide and expression in human colorectal cancer. Carcinogenesis 17: 1171-1174, 1997.
46. Pan, Y. H., E. O. Nuzum, L. A. Hanson, and D. G. Beer. Ki-ras activation and expression in transformed mouse lung cell lines. Mol. Carcinog. 3: 279-286, 1990.
47. Perrella, M. A., M. Yoshizumi, Z. Fen, J. C. Tsai, C. M. Hsieh, S. Kourembanas, and M. E. Lee. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J. Biol. Chem. 269: 14595-14600, 1994.
48. Punjabi, C. J., J. D. Laskin, K. J. Pendino, N. L. Goller, S. K. Durham, and D. L. Laskin. Production of nitric oxide by rat pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11: 165-172, 1994.
49. Radomski, M. W., R. M. J. Palmer, and S. Moncada. Glucocorticoids inhibit the expression of an inducible, but not constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87: 10043-10047, 1990.
50. Rajnakova, A., P. M. Y. Goh, S. T. F. Chan, S. S. Ngoi, A. Alponat, and S. Moochhala. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 18: 1841-1845, 1997.
51. Ray, K. P., and N. Kennard. Interleukin-1 induces a nuclear form of transcription factor NFκB in human lung epithelial cells. Agents Actions 38: C61-C63, 1993.
52. Robbing, R. A., P. J. Barnes, D. R. Springall, J. B. Warren, O. J. Kwon, L. D. K. Buttery, A. J. Wilson, D. A. Geller, and J. M. Polak. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 203: 209-218, 1994.
53. Robbins, R. A., D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, I. M. Adcock, V. Riveros-Moreno, S. Moncada, J. Polak, and P. J. Barnes. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198: 835-843, 1994.
54. Smith, G. J., S. M. Le Mesurier, M. L. de Montfort, and A. W. Lykke. Development and characterization of type 2 pneumocyte-related cell lines from normal adult mouse lung. Pathology 16: 401-405, 1984.
55. Smith, G. J., and A. W. Lykke. Characterization of a neoplastic epithelial cell strain derived by dexamethasone treatment of cultured normal mouse type 2 pneumocytes. J. Pathol. 147: 165-172, 1985.
56. Staal, F. J. T., M. Roederer, L. Herzenberg, and L. A. Herzenberg. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87: 9943-9947, 1990.
57. Stuehr, D. J., and C. F. Nathan. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555, 1989.
58. Szabo, C., and C. Thiemermann. Regulation of expression of the inducible isoform of nitric oxide synthase. Adv. Pharmacol. 34: 113-153, 1995.
59. Tayeh, M. A., and M. A. Marietta. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264: 19654-19658, 1989.
60. Thomsen, L. L., F. G. Lawton, R. G. Knowles, J. E. Beesley, V. Riveros-Moreno, and S. Moncada. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54: 1352-1354, 1994.
61. Thomsen, L. L., D. W. Miles, L. Happerfield, L. G. Bobrow, R. G. Knowles, and S. Moncada. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72: 41-44, 1995.
62. Wong, H. R., J. D. Finder, K. Wasserloos, C. J. Lowenstein, D. A. Geller, T. R. Billiar, B. R. Pitt, and P. Davies. Transcriptional regulation of iNOS by IL-1β in cultured rat pulmonary artery smooth muscle cells. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L166-L171, 1996.
63. Wong, H. R., M. Ryan, and J. R. Wispé. The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking Iκ-B degradation and NF-κB nuclear translocation. Biochem. Biophys. Res. Commun. 231: 257-263, 1997.
64. Xie, K., Z. Dong, and I. S. J. Fidler. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 59: 797-803, 1996.
65. Xie, K., S. Huang, Z. Dong, M. Gutman, and I. J. Fidler. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP31362. Cancer Res. 55: 3123-3131, 1995.
66. Xie, Q.-W., Y. Kashiwabara, and C. Nathan. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708, 1994.
67. Xu, J., Y. Wu, L. He, Y. Yang, S. A. Moore, and C. Y. Hsu. Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 235: 394-397, 1997.